GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (FRA:Q9T) » Definitions » Cash Flow from Discontinued Operations

ME Therapeutics Holding (FRA:Q9T) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Aug. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

ME Therapeutics Holding's cash flow from discontinued operations for the three months ended in Aug. 2024 was €0.00 Mil. It means ME Therapeutics Holding received €0.00 Mil from the sale of part of business quarterly. ME Therapeutics Holding's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Aug. 2024 was €0.00 Mil.


ME Therapeutics Holding Cash Flow from Discontinued Operations Historical Data

The historical data trend for ME Therapeutics Holding's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Cash Flow from Discontinued Operations Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23 Aug24
Cash Flow from Discontinued Operations
- - -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24 May24 Aug24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding Business Description

Industry
Comparable Companies
Traded in Other Exchanges
Address
177 Robson St., Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding Headlines

No Headlines